Gene Discovery, Gene Expression, Enzymes, Protein Manufacturing

Dyadic is harnessing the power of nature's gene pool for multi-billion dollar markets: agriculture, animal health and feed, chemical processing, diagnostic, health and beauty aids, industrial, textile and pharmaceutical industries.

Dyadic is applying its proprietary enabling biotechnologies for multi-billion dollar markets in industrial enzymes, biofuels and biotherapeutics.

Upcoming Events
2010 Proxy Statement
Annual Meeting of Stockholders
Wednesday, June 23, 2010, 10:00 am EST
Doubletree Hotel
4431 PGA Boulevard
Palm Beach Gardens, Florida

Click to learn more about Dyadic's Enzyme Solutions
	Enzyme Research & Development
	Food, Brewing & Animal Feed Enzymes
	BioFuels Enzymes
	Pulp & Paper Enzymes
	Textile Enzymes

INSIDESM
Dyadic uses a cutting edge patented C1 technology platform along with other proprietary technology to develop biofuels from agricultural by products such as corn stover and wheat straw. Dyadic uses this new technology for themselves and for others in the field of biotechnology.


	Press Release June 2010 Dyadic International Engages the Abraham Group as Strategic Advisor Press Release June 2010 Dyadic International Signs Term Sheet for Biopharmaceutical Applications Press Release May 2010 Rodman & Renshaw 6th Annual Healthcare Conference Presentation Dyadic International Reports 2010 First Quarter Financial Results Press Release April 2010 Dyadic International Stockholder Class Action Lawsuit Resolved Press Release March 2010 Dyadic International Reports Fiscal Year 2009 Financial Results World Biofuels Markets 2010 Conference March 2010 Presentation by Dyadic's CEO, Mark Emalfarb

built@zoomedia